2023-04-012024-03-312024-03-31false11630385VIDA ADIB LTD2024-09-24iso4217:GBPxbrli:pure116303852023-04-01116303852024-03-31116303852023-04-012024-03-31116303852022-04-01116303852023-03-31116303852022-04-012023-03-3111630385bus:SmallEntities2023-04-012024-03-3111630385bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3111630385bus:FullAccounts2023-04-012024-03-3111630385bus:PrivateLimitedCompanyLtd2023-04-012024-03-3111630385core:WithinOneYear2024-03-3111630385core:AfterOneYear2024-03-3111630385core:WithinOneYear2023-03-3111630385core:AfterOneYear2023-03-3111630385core:ShareCapital2024-03-3111630385core:SharePremium2024-03-3111630385core:RevaluationReserve2024-03-3111630385core:OtherReservesSubtotal2024-03-3111630385core:RetainedEarningsAccumulatedLosses2024-03-3111630385core:ShareCapital2023-03-3111630385core:SharePremium2023-03-3111630385core:RevaluationReserve2023-03-3111630385core:OtherReservesSubtotal2023-03-3111630385core:RetainedEarningsAccumulatedLosses2023-03-3111630385core:LandBuildings2024-03-3111630385core:PlantMachinery2024-03-3111630385core:Vehicles2024-03-3111630385core:FurnitureFittings2024-03-3111630385core:OfficeEquipment2024-03-3111630385core:NetGoodwill2024-03-3111630385core:IntangibleAssetsOtherThanGoodwill2024-03-3111630385core:ListedExchangeTraded2024-03-3111630385core:UnlistedNon-exchangeTraded2024-03-3111630385core:LandBuildings2023-03-3111630385core:PlantMachinery2023-03-3111630385core:Vehicles2023-03-3111630385core:FurnitureFittings2023-03-3111630385core:OfficeEquipment2023-03-3111630385core:NetGoodwill2023-03-3111630385core:IntangibleAssetsOtherThanGoodwill2023-03-3111630385core:ListedExchangeTraded2023-03-3111630385core:UnlistedNon-exchangeTraded2023-03-3111630385core:LandBuildings2023-04-012024-03-3111630385core:PlantMachinery2023-04-012024-03-3111630385core:Vehicles2023-04-012024-03-3111630385core:FurnitureFittings2023-04-012024-03-3111630385core:OfficeEquipment2023-04-012024-03-3111630385core:NetGoodwill2023-04-012024-03-3111630385core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3111630385core:ListedExchangeTraded2023-04-012024-03-3111630385core:UnlistedNon-exchangeTraded2023-04-012024-03-3111630385core:MoreThanFiveYears2023-04-012024-03-3111630385core:Non-currentFinancialInstruments2024-03-3111630385core:Non-currentFinancialInstruments2023-03-3111630385dpl:CostSales2023-04-012024-03-3111630385dpl:DistributionCosts2023-04-012024-03-3111630385core:LandBuildings2023-04-012024-03-3111630385core:PlantMachinery2023-04-012024-03-3111630385core:Vehicles2023-04-012024-03-3111630385core:FurnitureFittings2023-04-012024-03-3111630385core:OfficeEquipment2023-04-012024-03-3111630385dpl:AdministrativeExpenses2023-04-012024-03-3111630385core:NetGoodwill2023-04-012024-03-3111630385core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3111630385dpl:GroupUndertakings2023-04-012024-03-3111630385dpl:ParticipatingInterests2023-04-012024-03-3111630385dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3111630385core:ListedExchangeTraded2023-04-012024-03-3111630385dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3111630385core:UnlistedNon-exchangeTraded2023-04-012024-03-3111630385dpl:CostSales2022-04-012023-03-3111630385dpl:DistributionCosts2022-04-012023-03-3111630385core:LandBuildings2022-04-012023-03-3111630385core:PlantMachinery2022-04-012023-03-3111630385core:Vehicles2022-04-012023-03-3111630385core:FurnitureFittings2022-04-012023-03-3111630385core:OfficeEquipment2022-04-012023-03-3111630385dpl:AdministrativeExpenses2022-04-012023-03-3111630385core:NetGoodwill2022-04-012023-03-3111630385core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3111630385dpl:GroupUndertakings2022-04-012023-03-3111630385dpl:ParticipatingInterests2022-04-012023-03-3111630385dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3111630385core:ListedExchangeTraded2022-04-012023-03-3111630385dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3111630385core:UnlistedNon-exchangeTraded2022-04-012023-03-3111630385core:NetGoodwill2024-03-3111630385core:IntangibleAssetsOtherThanGoodwill2024-03-3111630385core:LandBuildings2024-03-3111630385core:PlantMachinery2024-03-3111630385core:Vehicles2024-03-3111630385core:FurnitureFittings2024-03-3111630385core:OfficeEquipment2024-03-3111630385core:AfterOneYear2024-03-3111630385core:WithinOneYear2024-03-3111630385core:ListedExchangeTraded2024-03-3111630385core:UnlistedNon-exchangeTraded2024-03-3111630385core:ShareCapital2024-03-3111630385core:SharePremium2024-03-3111630385core:RevaluationReserve2024-03-3111630385core:OtherReservesSubtotal2024-03-3111630385core:RetainedEarningsAccumulatedLosses2024-03-3111630385core:NetGoodwill2023-03-3111630385core:IntangibleAssetsOtherThanGoodwill2023-03-3111630385core:LandBuildings2023-03-3111630385core:PlantMachinery2023-03-3111630385core:Vehicles2023-03-3111630385core:FurnitureFittings2023-03-3111630385core:OfficeEquipment2023-03-3111630385core:AfterOneYear2023-03-3111630385core:WithinOneYear2023-03-3111630385core:ListedExchangeTraded2023-03-3111630385core:UnlistedNon-exchangeTraded2023-03-3111630385core:ShareCapital2023-03-3111630385core:SharePremium2023-03-3111630385core:RevaluationReserve2023-03-3111630385core:OtherReservesSubtotal2023-03-3111630385core:RetainedEarningsAccumulatedLosses2023-03-3111630385core:NetGoodwill2022-04-0111630385core:IntangibleAssetsOtherThanGoodwill2022-04-0111630385core:LandBuildings2022-04-0111630385core:PlantMachinery2022-04-0111630385core:Vehicles2022-04-0111630385core:FurnitureFittings2022-04-0111630385core:OfficeEquipment2022-04-0111630385core:AfterOneYear2022-04-0111630385core:WithinOneYear2022-04-0111630385core:ListedExchangeTraded2022-04-0111630385core:UnlistedNon-exchangeTraded2022-04-0111630385core:ShareCapital2022-04-0111630385core:SharePremium2022-04-0111630385core:RevaluationReserve2022-04-0111630385core:OtherReservesSubtotal2022-04-0111630385core:RetainedEarningsAccumulatedLosses2022-04-0111630385core:AfterOneYear2023-04-012024-03-3111630385core:WithinOneYear2023-04-012024-03-3111630385core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3111630385core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3111630385core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3111630385core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3111630385core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3111630385core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3111630385core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3111630385core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3111630385core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3111630385core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3111630385core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3111630385core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3111630385core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3111630385core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3111630385core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3111630385core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3111630385core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3111630385core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3111630385core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3111630385core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3111630385core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3111630385core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3111630385core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3111630385core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3111630385core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3111630385core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3111630385core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3111630385bus:Director12023-04-012024-03-31

VIDA ADIB LTD

Registered Number
11630385
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

VIDA ADIB LTD
Company Information
for the year from 1 April 2023 to 31 March 2024

Director

Dr Vida Adib

Registered Address

135 Oakwood Court
London
W14 8JS

Registered Number

11630385 (England and Wales)
VIDA ADIB LTD
Balance Sheet as at
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets38,4606,229
8,4606,229
Current assets
Cash at bank and on hand91,101120,240
91,101120,240
Creditors amounts falling due within one year4(15,850)(40,355)
Net current assets (liabilities)75,25179,885
Total assets less current liabilities83,71186,114
Net assets83,71186,114
Capital and reserves
Called up share capital100100
Profit and loss account83,61186,014
Shareholders' funds83,71186,114
The financial statements were approved and authorised for issue by the Director on 24 September 2024, and are signed on its behalf by:
Dr Vida Adib
Director
Registered Company No. 11630385
VIDA ADIB LTD
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
2.Average number of employees

20242023
Average number of employees during the year22
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 April 2312,11812,118
Additions3,4703,470
At 31 March 2415,58815,588
Depreciation and impairment
At 01 April 235,8895,889
Charge for year1,2391,239
At 31 March 247,1287,128
Net book value
At 31 March 248,4608,460
At 31 March 236,2296,229
4.Creditors: amounts due within one year

2024

2023

££
Taxation and social security6,0087,397
Other creditors5,73728,529
Accrued liabilities and deferred income4,1054,429
Total15,85040,355
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
5.Directors advances, credits and guarantees
At the balance sheet date, the director's loan account balance is in Credit of £1144 (2023 £2,857).